Pharmaceuticals, Biotechnology and Life Sciences
Research includes a potential new drug for colorectal cancer, as well as new studies on geriatric oncology and supportive care medicine.
Results from a phase 2 randomized trial study published today in Annals of Internal Medicine DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–Patients who underwent…
Harlan Levine, M.D., president of strategy and business ventures at City of Hope, joins the governing board of the bioscience…
The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research,…
The trial is one of the first CAR T cell trials nationwide to enroll prostate cancer patients DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope—City…
DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope—Saul Priceman, Ph.D., City of Hope assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation, and…
City of Hope’s Arthur D. Riggs, Ph.D., a world-renowned expert in molecular biology and diabetes, and his wife, Jane, established…
Recognizing immediate need, City of Hope accelerates plans to bring highly specialized cancer care, phase I-III clinical trials, and precision…
First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem…
The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…